Advantage of recombinant von Willebrand factor for peri-operative management in paediatric acquired von Willebrand syndrome

Haemophilia. 2018 May;24(3):e120-e121. doi: 10.1111/hae.13436. Epub 2018 Feb 8.

Authors

A C Weyand¹, R Jesudas², S W Pipe^{1

3}

Affiliations

¹ Department of paediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.
² Bleeding and Clotting Disorders Institute, Peoria, IL, USA.
³ Department of Pathology, University of Michigan, Ann Arbor, MI, USA.

PMID: 29418043
DOI: 10.1111/hae.13436

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Child, Preschool
Humans
Male
Perioperative Care
Postoperative Hemorrhage / prevention & control*
Pulmonary Valve Stenosis / blood*
Pulmonary Valve Stenosis / surgery
Recombinant Proteins / metabolism
Recombinant Proteins / therapeutic use*
Skull / surgery*
Skull Fractures / blood*
Skull Fractures / surgery
Treatment Outcome
von Willebrand Diseases / blood*
von Willebrand Diseases / surgery
von Willebrand Factor / metabolism
von Willebrand Factor / therapeutic use*

Substances

Recombinant Proteins
von Willebrand Factor